Clinical Trials Directory

Trials / Completed

CompletedNCT05914532

New Biomarkers in Axial Sypondyloarthropathy; SII and SIRI

In Patients With Axial Spondyloarthropathy; Evaluation of the Relationship Between the Systemic Immune Inflammation Index and the Systemic Inflammatory Response Index With Disease Activity and Function

Status
Completed
Phase
Study type
Observational
Enrollment
155 (actual)
Sponsor
Istanbul Training and Research Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

investigators aimed to evaluate the relationship between Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) and disease activity in patients with axial spondyloarthropathy (SpA).

Detailed description

The clinical characteristics and laboratory data of the patients and healthy controls participating in our study were obtained through the hospital system. Then, the new biomarkers SIRI and SII values were calculated. SIRI= neutrophil count\*monocyte count/lymphocyte count and SII= neutrophil count\*platelet count/lymphocyte count. Then, SIRI and SII values were compared between groups. The relationship between disease activity and SIRI and SII values in the patient group was examined.

Conditions

Interventions

TypeNameDescription
OTHERlab testingComplete blood count and erythrocyte sedimentation rate and C-reactive protein values of the participants were analyzed by laboratory test.

Timeline

Start date
2023-06-22
Primary completion
2023-07-10
Completion
2023-08-10
First posted
2023-06-22
Last updated
2023-08-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05914532. Inclusion in this directory is not an endorsement.